Athersys, Inc. (ATHXQ)
Develops stem cell therapies to treat neurological, inflammatory, and heart disease
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
ATHXQ is trading at penny-stock levels near its 52-week high, with the price holding above both its 50- and 200-day moving averages. Analyst coverage appears thin or unavailable for this micro-cap stock. The data reflects extreme volatility typical of sub-penny securities.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$6,171
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—